EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

SARS-CoV-2 seroprevalence in vaccine-naïve participants from the Democratic Republic of Congo, Guinea, Liberia, and Mali

Sylvain Laverdure, Donatien Kazadi, Kadidia Kone, Viviane Callier, Djeneba Dabitao, Dehkontee Dennis, Mory Cherif Haidara, Sally Hunsberger, Olivier Tshiani Mbaya, Renee Ridzon, Irini Sereti, Katy Shaw-Saliba und 1 weitere

International Journal of Infectious Diseases · 2024

DOI: 10.1016/j.ijid.2024.106985 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Infectious Diseases, 2024. Verfasst von Sylvain Laverdure und 12 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory, Frederick, MD. Electronic address: sylvain.laverdure@nih.gov. Hauptthemen laut MEDLINE: COVID-19, Vaccines. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, National Institutes of Health, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19VaccinesAdultHumansSARS-CoV-2COVID-19 VaccinesGuineaLiberiaMaliDemocratic Republic of the CongoSeroepidemiologic StudiesAntibodies, Viral

Stichwörter der Autor:innen

COVID-19InVITESARS-CoV-2SeroprevalenceVaccinesWest Africa

Substanzen

COVID-19 VaccinesVaccinesAntibodies, Viral

Autor:innen und Institutionen

  • Laboratory of Human Retrovirology and Immunoinformatics, Frederick National Laboratory, Frederick, MD. Electronic address: sylvain.laverdure@nih.gov.
  • Institut National de Recherche Biomédicale (INRB), Kinshasa, Democratic Republic of Congo.
  • University Clinical Research Center (UCRC), University of Sciences, Techniques, and Technologies of Bamako, Bamako, Mali.
  • Clinical Monitoring Research Program Directorate, Frederick National Laboratory, Frederick, MD.
  • Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), Monrovia, Liberia.
  • Partnership of Clinical Research in Guinea (PREGUI), Centre National de Formation et de Recherche en Santé Rurale de Maferinyah, Maferinyah, Guinea.

Förderung

  • NCI NIH HHS
  • National Institutes of Health
  • National Cancer Institute

Zitieren

APA

Laverdure, S., Kazadi, D., Kone, K., Callier, V., Dabitao, D., Dennis, D., Haidara, M. C., Hunsberger, S., Mbaya, O. T., Ridzon, R., Sereti, I., Shaw-Saliba, K., & InVITE Study Team (2024). SARS-CoV-2 seroprevalence in vaccine-naïve participants from the Democratic Republic of Congo, Guinea, Liberia, and Mali. International Journal of Infectious Diseases. https://doi.org/10.1016/j.ijid.2024.106985

Vancouver

Laverdure S, Kazadi D, Kone K, Callier V, Dabitao D, Dennis D, et al. SARS-CoV-2 seroprevalence in vaccine-naïve participants from the Democratic Republic of Congo, Guinea, Liberia, and Mali. International Journal of Infectious Diseases. 2024. doi:10.1016/j.ijid.2024.106985

BibTeX
@article{Laverdure2024,
  author = {Laverdure, Sylvain and Kazadi, Donatien and Kone, Kadidia and Callier, Viviane and Dabitao, Djeneba and Dennis, Dehkontee and Haidara, Mory Cherif and Hunsberger, Sally and Mbaya, Olivier Tshiani and Ridzon, Renee and Sereti, Irini and Shaw-Saliba, Katy and InVITE Study Team, InVITE Study Team},
  title = {SARS-CoV-2 seroprevalence in vaccine-naïve participants from the Democratic Republic of Congo, Guinea, Liberia, and Mali},
  journal = {International Journal of Infectious Diseases},
  year = {2024},
  doi = {10.1016/j.ijid.2024.106985}
}
Kostenlos starten →